Structural Model for Recruitment of RIT1 to the LZTR1 E3 Ligase: Evidences from an Integrated Computational Approach

Antonella Paladino1, Fulvio D'Angelo1,2, Teresa Maria Rosaria Noviello1,3

  • 1BIOGEM Istituto di Ricerche Genetiche "G. Salvatore", via Camporeale, Ariano Irpino 83031, Italy.

Insights

Leucine-zipper transcription regulator 1 (LZTR1) protein interactions were modeled computationally. This study reveals how LZTR1 mutations impact substrate recognition, offering insights into cancer and developmental disorders for new therapeutic strategies.

Area of Science:

  • Molecular biology
  • Structural biology
  • Computational biology

Background:

  • Leucine-zipper transcription regulator 1 (LZTR1) is a tumor suppressor gene implicated in cancers and developmental disorders.
  • LZTR1 functions as an adaptor protein in the Cullin3-RING ligase E3 (CRL3) complex, facilitating substrate ubiquitination and proteasomal degradation.
  • The Kelch propeller domain of LZTR1 is crucial for substrate recognition, but its structure remains experimentally unsolved.

Purpose of the Study:

  • To elucidate the interaction model between LZTR1 and its substrate RIT1 using computational methods.
  • To understand the structural basis of LZTR1 function and the impact of disease-associated mutations.
  • To provide insights for developing novel therapeutic strategies targeting CRL3 machinery.

Main Methods:

  • Integrated computational approach combining molecular modeling and docking techniques.
  • Molecular dynamics (MD) simulations to analyze conformational dynamics of LZTR1.
  • Identification and characterization of key interactions and mutation effects.

Main Results:

  • The LZTR1-RIT1 interaction is stabilized by an electrostatic bond network.
  • MD simulations revealed differential conformational dynamics of LZTR1.
  • Specific mutations (G248R, R283Q) were identified as damaging to RIT1 substrate recognition, while R412C may act as an allosteric mutation.

Conclusions:

  • The study provides crucial structural insights into the LZTR1-RIT1 interaction mechanism.
  • Findings highlight the role of specific LZTR1 mutations in disease pathogenesis.
  • The results support targeting CRL3 complexes for drug discovery in cancer and developmental disorders.